Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers.

Kawaguchi T, Komatsu S, Ichikawa D, Tsujiura M, Takeshita H, Hirajima S, Miyamae M, Okajima W, Ohashi T, Imamura T, Kiuchi J, Konishi H, Shiozaki A, Okamoto K, Otsuji E.

Int J Mol Sci. 2016 Sep 1;17(9). pii: E1459. doi: 10.3390/ijms17091459. Review.

2.

The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.

Koenig EM, Fisher C, Bernard H, Wolenski FS, Gerrein J, Carsillo M, Gallacher M, Tse A, Peters R, Smith A, Meehan A, Tirrell S, Kirby P.

BMC Genomics. 2016 Aug 17;17:649. doi: 10.1186/s12864-016-2958-x.

3.

New insights on the role of epigenetic alterations in hepatocellular carcinoma.

Frau M, Feo CF, Feo F, Pascale RM.

J Hepatocell Carcinoma. 2014 Jun 12;1:65-83. doi: 10.2147/JHC.S44506. eCollection 2014. Review.

4.

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma.

Li L, Diao W, Zen K.

J Hepatocell Carcinoma. 2014 May 21;1:21-33. doi: 10.2147/JHC.S44463. eCollection 2014. Review.

5.

MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.

Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D.

World J Gastroenterol. 2016 Apr 21;22(15):3907-36. doi: 10.3748/wjg.v22.i15.3907. Review.

6.

MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression.

Aschrafi A, Verheijen JM, Gordebeke PM, Olde Loohuis NF, Menting K, Jager A, Palkovits M, Geenen B, Kos A, Martens GJ, Glennon JC, Kaplan BB, Gaszner B, Kozicz T.

J Psychiatry Neurosci. 2016 Aug;41(5):342-53. doi: 10.1503/jpn.150154.

7.

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Bernuzzi F, Marabita F, Lleo A, Carbone M, Mirolo M, Marzioni M, Alpini G, Alvaro D, Boberg KM, Locati M, Torzilli G, Rimassa L, Piscaglia F, He XS, Bowlus CL, Yang GX, Gershwin ME, Invernizzi P.

Clin Exp Immunol. 2016 Jul;185(1):61-71. doi: 10.1111/cei.12776. Epub 2016 May 17.

PMID:
26864161
8.

Identification of valid reference genes for microRNA expression studies in a hepatitis B virus replicating liver cell line.

Jacobsen KS, Nielsen KO, Winther TN, Glebe D, Pociot F, Hogh B.

BMC Res Notes. 2016 Jan 22;9:38. doi: 10.1186/s13104-016-1848-2.

9.

MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.

Tessitore A, Cicciarelli G, Del Vecchio F, Gaggiano A, Verzella D, Fischietti M, Mastroiaco V, Vetuschi A, Sferra R, Barnabei R, Capece D, Zazzeroni F, Alesse E.

BMC Cancer. 2016 Jan 5;16:3. doi: 10.1186/s12885-015-2007-1.

10.

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.

Fornari F, Ferracin M, Trerè D, Milazzo M, Marinelli S, Galassi M, Venerandi L, Pollutri D, Patrizi C, Borghi A, Foschi FG, Stefanini GF, Negrini M, Bolondi L, Gramantieri L.

PLoS One. 2015 Oct 28;10(10):e0141448. doi: 10.1371/journal.pone.0141448. eCollection 2015.

11.

MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.

Jin BX, Zhang YH, Jin WJ, Sun XY, Qiao GF, Wei YY, Sun LB, Zhang WH, Li N.

Sci Rep. 2015 Oct 12;5:15026. doi: 10.1038/srep15026.

12.

Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.

Awan FM, Naz A, Obaid A, Ali A, Ahmad J, Anjum S, Janjua HA.

PLoS One. 2015 Sep 28;10(9):e0138913. doi: 10.1371/journal.pone.0138913. eCollection 2015.

13.

Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.

Motawi TK, Shaker OG, El-Maraghy SA, Senousy MA.

PLoS One. 2015 Sep 9;10(9):e0137706. doi: 10.1371/journal.pone.0137706. eCollection 2015.

14.

Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.

Li S, Li F, Niu R, Zhang H, Cui A, An W, Wang X.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8048-56. eCollection 2015.

15.

Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Li MH, Fu SB, Xiao HS.

Acta Pharmacol Sin. 2015 Oct;36(10):1200-11. doi: 10.1038/aps.2015.67. Epub 2015 Aug 24. Review.

16.

MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.

Anwar SL, Lehmann U.

J Clin Med. 2015 Aug 18;4(8):1631-50. doi: 10.3390/jcm4081631. Review.

17.

Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.

Teng J, Sun F, Yu PF, Li JX, Yuan D, Chang J, Lin SH.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7282-6. eCollection 2015.

18.

Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.

El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A.

J Virol. 2015 Sep;89(18):9454-64. doi: 10.1128/JVI.00955-15. Epub 2015 Jul 8.

19.

Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.

Chen Y, Chen J, Liu Y, Li S, Huang P.

Med Sci Monit. 2015 Jun 29;21:1864-71. doi: 10.12659/MSM.893082.

20.

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.

Fischer D, Wahlfors T, Mattila H, Oja H, Tammela TL, Schleutker J.

PLoS One. 2015 May 28;10(5):e0127427. doi: 10.1371/journal.pone.0127427. eCollection 2015.

Items per page

Supplemental Content

Write to the Help Desk